Ô¨Åts and harms
of screening
asymptomatic
individuals with ABI
Incremental value of
adding ABI to
traditional risk
assessment tools
(Framingham risk
assessment)

Quality of
evidence

Data source

Finding

Multiple nonrandomized
diagnostic studies with
comparison with the gold
standard
Nonrandomized diagnostic
studies with comparison
with the gold standard

ABI <0.9 has a sensitivity ranging from 79% to
9